Isolation of Bioactive Compounds from Pistacia integerrima with Promising Effects on Reverse Cancer Multidrug Resistance

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Russian journal of bioorganic chemistry

• Publication date

  2021-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1134/S1068162021050204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversal of Multidrug Resistance in Mouse Lymphoma Cells by Extracts and Flavonoids from Pistacia integerrima.

  2016cited by this paper
• Phosphodiesterase-1 Inhibitory Activity of Two Flavonoids Isolated from Pistacia integerrima J. L. Stewart Galls

  2015cited by this paper
• Quantitative expression of human drug transporter proteins in lung tissues: analysis of regional, gender, and interindividual differences by liquid chromatography-tandem mass spectrometry.

  2013cited by this paper
• Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study.

  2013cited by this paper
• Avogadro: an advanced semantic chemical editor, visualization, and analysis platform

  2012cited by this paper
• Pistagremic acid, a glucosidase inhibitor from Pistacia integerrima.

  2012cited by this paper
• Pistagremic acid a new leishmanicidal triterpene isolated from Pistacia integerrima Stewart

  2012cited by this paper
• iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis

  2011cited by this paper
• Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).

  2011cited by this paper
• Pharmacognostic and phytochemical investigation of the stem bark of Pistacia integerrima Stew ex Brandis

  2011cited by this paper
• The structure and functions of P-glycoprotein.

  2010cited by this paper
• Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice.

  2010cited by this paper
• ABCG2: determining its relevance in clinical drug resistance

  2007cited by this paper
• Modulation of the Brain Distribution of Imatinib and its Metabolites in Mice by Valspodar, Zosuquidar and Elacridar

  2007cited by this paper
• Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• Transport of glutathione and glutathione conjugates by MRP1.

  2006cited by this paper
• The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data

  2006cited by this paper
• The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

  2006cited by this paper
• Personal Experience with Four Kinds of Chemical Structure Drawing Software: Review on ChemDraw, ChemWindow, ISIS/Draw, and ChemSketch

  2004cited by this paper
• Investigation of MRP‐1 protein and MDR‐1 P‐glycoprotein expression in invasive breast cancer: A prognostic study

  2004cited by this paper
• The ABC transporter structure and mechanism: perspectives on recent research

  2004cited by this paper
• Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.

  2003cited by this paper
• The role of ABC transporters in clinical practice.

  2003cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• Expression of Multidrug Resistance-Associated Markers, Their Relation to Quantitative Pathologic Tumour Characteristics and Prognosis in Advanced Ovarian Cancer

  2002cited by this paper
• Overview: ABC Transporters and Human Disease

  2001cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• The role of stereoselectivity of chemosensitizers in the reversal of multidrug resistance of mouse lymphoma cells.

  1998cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• P-glycoproteins: mediators of multidrug resistance.

  1993cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.

  1990cited by this paper
• Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

  1987cited by this paper

• Xanthine oxidase inhibitory potential of flavonoids from Pistacia integerrima: insights from molecular docking, MD simulations, SwissADME ADMET analysis and StopTox toxicity profile evaluation

  2026cites this paper
• A multi-faceted pharmacology of Pistacia Integerrima mitigating asthma: a review on ethnopharmacology, phytochemicals, mechanisms, and formulations

  2026cites this paper
• Study on the Chemical Composition and Multidrug Resistance Reversal Activity of Euphorbia uralensis (Euphorbiaceae)

  2025cites this paper
• Rising above: exploring the therapeutic potential of natural product-based compounds in human cancer treatment

  2025cites this paper
• Deciphering the multi-scale mechanism of herbal phytoconstituents in targeting breast cancer: a computational pharmacological perspective

  2024cites this paper
• In vitro Leishmanicidal potential and silico study of flavonoids isolated from Pistacia integerrima Stew ex Brandis

  2023cites this paper
• Molecular Modeling Strategies of Cancer Multidrug Resistance.

  2021cites this paper
• Advances in Research on Food Bioactive Molecules and Health

  2021cites this paper